Bioventus Inc. revenue for the last year amounted to 573.28 M USD, the most of which — 261.29 M USD — came from its highest performing source at the moment, Pain Treatments, the year earlier bringing 220.80 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Bioventus Inc. 506.81 M USD, and the year before that — 449.86 M USD.